ICNSl logo no-tagline copy

PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

CURRENT ISSUE

Assessment of Cognitive and Neurologic Recovery in Ischemic Stroke Drug Trials: Results from a Randomized, Double-blind, Placebo-controlled Study
by Franco Di Cesare, MD; Jessica Mancuso, PhD; Brian Silver, MD; and Peter T. Loudon, PhD Dr. Di Cesare...
Read More
pennington_sep_oct_2016_art
Eszopiclone-induced Parasomnia with Suicide Attempt: A Case Report
by J. Gibson Pennington, MD, and Jeffrey Guina, MD From Wright-Patterson Air Force Base and Wright State...
Read More
scarff_sep_oct_2016_art
Cariprazine for Schizophrenia and Bipolar Disorder
by Jonathan R. Scarff, MD Dr. Scarff is a staff psychiatrist at the Veterans Affairs Outpatient Clinic...
Read More
risk_sep_oct_2016_art
Consent to Treatment of Minors, Revisited
by Ann McNary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Innov Clin...
Read More
dd_sep_oct_2016_art
Differential Diagnoses: Delirium or Dementia?
by Steven Lippmann, MD, and Malathi Latha Perugula, MD The authors are from the Department of Psychiatry...
Read More
The Neuroscience Report—Vol. 45 (September 15, 2016): Schizophrenia
The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each...
Read More
01_IICN_Jul_Aug_2016
Editor’s Message—Issue Highlights, July–August 2016
Dear Colleagues: Welcome to the July–August 2016 issue of Innovations in Clinical Neuroscience. We start...
Read More
Aigbogun_J_A_2016_Art
Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases
by Joanna P. MacEwan, PhD; Seth Seabury, PhD; Myrlene Sanon Aigbogun, MPH; Siddhesh Kamat, MS, MBA; Emma...
Read More
Scarff_J_A_2016_Art
Brexpiprazole: A New Treatment Option for Schizophrenia
by Jonathan R. Scarff, MD Dr. Scarff is with Veterans Affairs Outpatient Clinic, Spartanburg, South Carolina....
Read More
Mirshafiey_J_A_2016_Art
The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis
by Nazanin Arjomand Fard, MSci; Gholamreza Azizi, PhD; and Abbas Mirshafiey, PhD Dr. Fard is with Kish...
Read More

LATEST DIGITAL EDITION

ARCHIVES